These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26666150)

  • 61. An update on the management of nephropathy in type 2 diabetes.
    Zhao HL; Thomas GN; Leung W; Tomlinson B; Hsu YH; Chan P
    J Chin Med Assoc; 2003 Nov; 66(11):627-36. PubMed ID: 14768849
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Diabetic nephropathy].
    Sämann A; Wolf G
    Internist (Berl); 2012 Oct; 53(10):1195-206. PubMed ID: 22961072
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nephropathy in type 2 diabetics : predictive factors and evolving aspects.
    Ben Naceur K; Abdesselem H; Zribi S; Sebai I; Ounaissa K; Amrouche C
    Tunis Med; 2021 Avril; 99(4):466-474. PubMed ID: 35244932
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.
    Zanchi A; Jehle AW; Lamine F; Vogt B; Czerlau C; Bilz S; Seeger H; de Seigneux S
    Swiss Med Wkly; 2023 Jan; 153():40004. PubMed ID: 36652726
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy.
    Haneda M; Utsunomiya K; Koya D; Babazono T; Moriya T; Makino H; Kimura K; Suzuki Y; Wada T; Ogawa S; Inaba M; Kanno Y; Shigematsu T; Masakane I; Tsuchiya K; Honda K; Ichikawa K; Shide K
    Clin Exp Nephrol; 2015 Feb; 19(1):1-5. PubMed ID: 25527479
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting inflammation in diabetic nephropathy: a tale of hope.
    Moreno JA; Gomez-Guerrero C; Mas S; Sanz AB; Lorenzo O; Ruiz-Ortega M; Opazo L; Mezzano S; Egido J
    Expert Opin Investig Drugs; 2018 Nov; 27(11):917-930. PubMed ID: 30334635
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective.
    Xue R; Gui D; Zheng L; Zhai R; Wang F; Wang N
    J Diabetes Res; 2017; 2017():1839809. PubMed ID: 28386567
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Resistivity index in the diagnosis and assessment of loss of renal function in diabetic nephropathy.
    Jinadu YO; Raji YR; Ajayi SO; Salako BL; Arije A; Kadiri S
    Cardiovasc J Afr; 2022 Jan-Feb 23; 33(1):26-32. PubMed ID: 34309616
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diabetic Nephropathy: A Comparison of the Clinical and Pathological Features between the CKD Risk Classification and the Classification of Diabetic Nephropathy 2014 in Japan.
    Furuichi K; Shimizu M; Hara A; Toyama T; Wada T
    Intern Med; 2018 Dec; 57(23):3345-3350. PubMed ID: 30101924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diabetic nephropathy: What does the future hold?
    Montero RM; Covic A; Gnudi L; Goldsmith D
    Int Urol Nephrol; 2016 Jan; 48(1):99-113. PubMed ID: 26438328
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines.
    Selby NM; Taal MW
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():3-15. PubMed ID: 32267079
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early functional and metabolic disorders in children with type I diabetes mellitus and diabetic nephropathy.
    Burlaka I; Maidannyk V
    Pediatr Endocrinol Diabetes Metab; 2021; 27(3):170-177. PubMed ID: 34743502
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A drug test with indomethacin in the diagnosis of subclinical forms of diabetic nephropathy].
    Man'kovskiĭ BN; Tadzhieva DCh
    Lik Sprava; 1999 Mar; (2):83-7. PubMed ID: 10424051
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gene therapy, a targeted treatment for diabetic nephropathy.
    Lin X; Tao L; Tang D
    Curr Med Chem; 2013; 20(30):3774-84. PubMed ID: 23895680
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Prevalence and Management of Diabetic Nephropathy in Asia.
    Tomino Y; Gohda T
    Kidney Dis (Basel); 2015 May; 1(1):52-60. PubMed ID: 27536665
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.
    Bakris GL
    Mayo Clin Proc; 2011 May; 86(5):444-56. PubMed ID: 21531886
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinico-pathological features of kidney disease in diabetic cases.
    Furuichi K; Shimizu M; Okada H; Narita I; Wada T
    Clin Exp Nephrol; 2018 Oct; 22(5):1046-1051. PubMed ID: 29564666
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiovascular disease in patients with diabetic nephropathy.
    Aso Y
    Curr Mol Med; 2008 Sep; 8(6):533-43. PubMed ID: 18781960
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low-intensity shockwave therapy in the treatment of diabetic nephropathy: a prospective Phase 1 study.
    Skov-Jeppesen SM; Yderstraede KB; Bistrup C; Jensen BL; Marcussen N; Hanna M; Lund L
    Nephrol Dial Transplant; 2020 Aug; 35(8):1385-1392. PubMed ID: 30590575
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes.
    Kim SS; Kim JH; Kim IJ
    Endocrinol Metab (Seoul); 2016 Jun; 31(2):245-53. PubMed ID: 27246284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.